Duke Researchers Develop AI for Cardiovascular Care

The team aims to assist heart failure patients and address the shortage of cardiologists in rural regions.

Updated on Oct. 15, 2026 in Heart Disease

Duke Researchers Develop AI for Cardiovascular Care

Live Poll

Would you trust an autonomous AI system to monitor your heart health between doctor visits?

Duke University researchers have received $15.5 million to develop an agentic AI system designed to support heart failure patients autonomously between medical appointments. The project, part of the larger ADVOCATE program, seeks to reduce the need for in-person care and emergency room visits.

Why it matters

This initiative addresses the significant gap in cardiovascular access, as nearly half of all U.S. counties currently lack a practicing cardiologist. By leveraging AI agents, the consortium hopes to provide continuous monitoring and improve outcomes for heart failure patients nationwide.

The ADVOCATE program received $62.7 million in total funding to develop systems to be tested across five health systems and rural sites. These efforts follow 2023 statistics showing cardiovascular diseases caused over 900,000 deaths in the U.S.

The players

Duke Clinical Research Institute

This organization is a major academic research organization that conducts large-scale clinical trials and health outcomes studies.

Stanford University

This private research university is a global leader in artificial intelligence development and medical innovation.

The details

The SYMPHONY consortium, led by the Duke Clinical Research Institute, will utilize electronic health records and data from the American Heart Association to assess AI performance. Three health-tech companies are creating the systems, while Stanford University researchers develop a supervisory layer to ensure safety and evaluate the need for human oversight.

In 2023, cardiovascular diseases killed over 900,000 Americans.
The Duke team plans to be prepared for implementation within one year.
The consortium aims to conduct an actual platform trial within two years.

Health Landscape

The SYMPHONY consortium uses the American Heart Association data guidelines to ensure their AI agents meet established clinical benchmarks. This project follows established standards set by these guidelines to validate the performance of new autonomous health monitoring tools.

This development could eventually offer heart failure patients continuous care and monitoring without needing to travel to a specialist. It aims to bridge the gap for residents in rural areas who lack local access to cardiologists.

The takeaway

This technology highlights a shift toward using autonomous AI to extend the reach of specialized medicine into underserved regions. Patients should anticipate that these digital tools may soon change how heart health is monitored outside of traditional clinic visits.